TOKYO: Saudi Arabia is establishing itself as a regional leader in digital health regulation by integrating advanced technologies into the Saudi Food and Drug Authority’s (SFDA) pharmacovigilance and cosmetic safety oversight.
In line with Vision 2030’s digital goals, these projects are creating new standards for using data to protect public health, according to the SFDA.
A report by the Oxford Business Group says the transformation began with modernising the National Pharmacovigilance Centre’s adverse reaction reporting system. Moving from paper-based submissions to the fully digital “Saudi Vigilance” platform marked a significant step forward.
The introduction of smart reporting forms with structured data fields and behavioural nudges grounded in psychological principles significantly improved reporting quality and completion rates.
This digital foundation enabled the development of centralised dashboards that provide real-time analysis of adverse events, enabling early identification of safety signals and under-reporting trends.
